Filing metadata

Accession number
0001209191-21-046011
Form type
Form 4
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Jul 08, 2021
Reporting period
Jul 06, 2021
Description
Insider transaction

Explore SEC Filings Hub